Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04113694 · ClinicalTrials.gov registry record · NA
Evaluation of Extended Wear Infusion Set (EWIS) in Patients With Type 1 Diabetes
A NA study of Diabetes, sponsored by Medtronic Diabetes.
- Completed
- Registry status
- NA
- Development phase
- 291
- Enrollment target
- 15
- Study locations
NCT04113694 is a NA study of Diabetes that has completed, run by Medtronic Diabetes. The registered enrollment target is 291 participants, below the 3,027-participant average among 338 other Diabetes trials with a reported enrollment target (90% lower). The trial reports 15 study locations across 12 states.
The verdict
NCT04113694, a NA study of Diabetes, has completed, sponsored by Medtronic Diabetes.
- COMPLETED
- Registry status
- NA
- Development phase
- 291 participants
- Enrollment target
- 15
- Study locations
Study Summary
The purpose of this study is to collect confirmatory clinical data to support 6 or 7 days wear of EWIS (Extended Wear Infusion Set).
Conditions Studied
Interventions
- DEVICE Extended Infusion Set
Study Locations (15)
California
- AMCR Institute - Escondido
- Stanford University - Palo Alto
- SoCal Diabetes - West Covina
Georgia
- Atlanta Diabetes Associates - Atlanta
- Endocrine Research Solutions - Roswell
Arkansas
- Medical Investigations - Little Rock
Colorado
- Barbara Davis Center for Childhood Diabetes - Aurora
Florida
- Metabolic Research Institute - West Palm Beach
Iowa
- Iowa Diabetes and Endocrinology Center - West Des Moines
Michigan
- Grunberger Diabetes Institute - Bloomfield Hills
Minnesota
- Mayo Clinic (Rochester MN) - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 291 participants |
| Start Date | 2019-10-14 |
| Est. Completion | 2020-11-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04113694
The ClinicalTrials.gov registry entry for NCT04113694 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 291 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,027-participant average among 338 other Diabetes trials with a reported enrollment target (90% lower). The listed sponsor is Medtronic Diabetes, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Extended Infusion Set is the first listed.
NCT04113694 reports 15 study locations spanning 12 distinct geographic areas - top geographies include California, Georgia, Arkansas.
Frequently Asked Questions
What is clinical trial NCT04113694 about?
NCT04113694 is a clinical study titled "Evaluation of Extended Wear Infusion Set (EWIS) in Patients With Type 1 Diabetes". The purpose of this study is to collect confirmatory clinical data to support 6 or 7 days wear of EWIS (Extended Wear Infusion Set).
What is the current status of trial NCT04113694?
This trial is currently completed. It is a NA study. The enrollment target is 291 participants. The study started on 2019-10-14. Estimated completion is 2020-11-05.
What conditions does trial NCT04113694 study?
This clinical trial studies the following conditions: Diabetes.
What interventions are being tested in trial NCT04113694?
The interventions under investigation include: Extended Infusion Set (DEVICE).
Who is sponsoring clinical trial NCT04113694?
This trial is sponsored by Medtronic Diabetes, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04113694 being conducted?
This trial has 15 study locations across Arkansas, California, Colorado, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
-
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
RECRUITING · NA
-
Bringing Advocacy Via Digital Guide to the Emergency Department (Project BADGE)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.